Biostealth Technology​

Next generation solutions to increase the biocompatibility and extend the lifespan of medical devices and life support equipment

BCI’s biostealth technology is designed to increase the biocompatibility and durability of medical devices, rendering these devices highly resistant to physiologic reactions and extending their lifespan.

BCI has pioneered the development of the patented technologies Protego®, Facta®, Firmo®, and D-FendorTM utilizing a combination of plant-based active molecules that bond permanently with materials used in the manufacturing of medical devices.

BCI’s proprietary biostealth technologies are designed to protect medical devices from the risks of immune rejection and inflammatory reactions, particularly the increased risk of thrombosis, infection, and calcification.

BCI-biocompatibility-innovation-biostealth-technology-6
BCI-biocompatibility-innovation-biostealth-technology-4
BCI-biocompatibility-innovation-biostealth-technology-3
BCI-biocompatibility-innovation-biostealth-technology-2
BCI-biocompatibility-innovation-biostealth-technology-1

Nature-Based Technology

For medical devices made with polymers, metals, and ceramics
For conventionally cross-linked biologic medical devices
For biologic medical devices, replacing current cross-linking methods and fixatives
For dental implants, improving osseointegration and peri-implant mucosal tissue seal

One platform, numerous technologies, unlimited applications

Eliminate the primary causes of medical device failure

Our technology counteracts the body’s adverse reactions to prosthetic materials, preventing post-implant degenerative processes that adversely affect the durability and the proper functionality of these medical devices.

Devices treated with our technology are designed to last longer, reduce health and social costs in terms of patient care, and improve the quality of life for patients.

Key Benefits

Significant patient and healthcare upside plus access to new patient populations

BCI technologies are built to offer vital benefits to device manufactures, healthcare workers, and their patients.

for virtually all new generation and currently approved medical devices

superior performance and substantially increased lifespan

rapidly scalable

regulatory-friendly

improved patient quality of life and clinical management

reduced burden on healthcare systems

for expanded patient populations previously ineligible for certain medical devices

BCI prioritizes patient safety and quality of life above all else, advancing at its core sustainable and responsible solutions to unmet clinical needs.

We are deeply committed to ensuring the safety of our pioneering technology. BCI technology continues to be subject to extensive testing and independent analysis as we move toward approval by the FDA.

We have partnered with internationally renowned scientists, researchers, medical experts, and leading manufacturers to test the efficacy and safety of BCI’s technology solutions.